#Thermography Cancer Screening

[webscarlet]

Thermography Breast Scan: Early Detection at Reenew Energy Wellness Center

In recent years, thermography has emerged as a revolutionary tool in the early detection of breast abnormalities. With its non-invasive nature and ability to detect changes in breast tissue before they become palpable lumps, it has gained significant attention from women's health advocates and medical professionals alike. At Reenew Energy Wellness Center, we are proud to offer this cutting-edge technology to support women in their breast health journeys.

Understanding Thermography

What is Thermography?

Thermography, also known as digital infrared thermal imaging (DITI), is a technique that captures the thermal patterns on the surface of the skin. Unlike traditional mammograms, which use X-rays to image the breast tissue, thermography detects heat and blood flow in tissues. This method offers a unique approach to identifying potential health issues by highlighting areas of inflammation or abnormal vascular activity.

How Does Thermography Work?

The process involves using a specialized camera to take thermal images of the breast. These images are then analyzed for patterns that may indicate the presence of abnormalities. Since cancerous tissues often exhibit higher temperatures due to increased blood flow and metabolic activity, thermography can detect these variations early on.

Why Choose Thermography?

Thermography is a compelling option for many reasons:

Non-invasive and Painless: No compression or radiation is involved, making it a comfortable experience.

Early Detection: Able to identify changes in breast tissue before they develop into lumps.

Complementary Tool: Enhances traditional screening methods, offering a broader perspective on breast health.

Benefits of Thermography for Breast Health

Early Detection and Prevention

One of the most significant advantages of thermography is its ability to detect changes early. Traditional mammograms often only identify cancers once they have formed into lumps, which can be too late for some aggressive types. Thermography, on the other hand, can detect changes in blood flow and heat patterns that may indicate the early stages of tumor development.

Safe and Comfortable Screening

Many women avoid regular mammograms due to the discomfort and exposure to radiation. Thermography offers a safe alternative:

No Radiation: Completely free from harmful radiation, making it suitable for regular monitoring.

No Contact: The procedure does not require any physical contact or compression of the breast.

Comprehensive Breast Health Monitoring

Thermography provides a comprehensive analysis by detecting various conditions that may not be visible in traditional imaging:

Inflammation: Early signs of inflammation can be indicative of underlying issues.

Vascular Activity: Abnormal blood flow patterns can be an early warning sign of cancer.

How Thermography Fits into Your Health Regimen

Integrating Thermography with Other Screenings

Thermography should be seen as a complementary tool rather than a replacement for mammograms or ultrasounds. By integrating thermography into your regular health check-ups, you can gain a more comprehensive understanding of your breast health.

Personalized Health Plans

At Reenew Energy Wellness Center, we believe in a holistic approach to health. Our experts work with you to create personalized health plans that incorporate thermography alongside other diagnostic tools. This ensures you receive the most accurate and thorough assessments possible.

Thermography at Reenew Energy Wellness Center

Our Commitment to Excellence

Reenew Energy Wellness Center is dedicated to providing the highest quality care. Our state-of-the-art thermography equipment and trained professionals ensure you receive the most accurate and reliable screenings.

Expert Curation and Tasting Notes

Our team of experts curates a variety of thermography services tailored to your individual needs. Just as a sommelier selects the finest wines, we offer expertly chosen diagnostic tools and techniques to enhance your health and well-being.

Exclusive Deals for Subscribers

Join our community to access exclusive deals and promotions. Whether you're a wellness enthusiast or a medical professional, our subscription plans offer valuable resources and discounts.

Sense of Community

We believe in fostering a sense of community among our clients. By joining Reenew Energy Wellness Center, you become part of a supportive network of individuals dedicated to better health.

Frequently Asked Questions

Is Thermography Safe?

Yes, thermography is a safe and non-invasive procedure. It does not involve radiation or physical contact, making it suitable for regular monitoring.

How Often Should I Get a Thermography Breast Scan?

Frequency depends on individual risk factors and health history. Our experts at Reenew Energy Wellness Center can help determine the best schedule for you.

Can Thermography Replace Mammograms?

Thermography is a complementary tool, not a replacement. It provides additional insights that enhance traditional screening methods.

Are you ready to take control of your breast health? Schedule your thermography breast scan at Reenew Energy Wellness Center today. Our professional and friendly staff are here to guide you every step of the way.

Contact us at 801-300-9992 to book your appointment and join our community of health-conscious individuals. Don't wait—early detection can make all the difference.

[drtomroselle]

Thermography as a Breast Cancer Screening Technique

Dr. Tom Roselle DC highlights the latest technological advances in thermography for early detection of breast cancer. He emphasizes how recent developments in thermal sensors, imaging protocols, and computer-aided software diagnostics are revolutionizing the potential for thermography as a mainstream modality and effective technology for early detection of breast cancer.

  For all episodes of Ageless Health® with Dr. Tom Roselle, DC, please visit https://www.drtomroselle.com/ageless-health-podcast/

  #agelesshealth #podcast @wmaldc

AGELESS HEALTH® with Dr. Tom Roselle, DC - PODACST AVAILABLE!

[astute1902]

Unveiling the Future: Projections for Breast Cancer Screening Market Growth

Astute Analytica, a team of experts with extensive experience, has recently published a new report on the Global Breast Cancer Screening Market. The report provides valuable insights into the market’s competitive environment, growth prospects, and upcoming opportunities. It covers the strategies adopted by major global players in the industry, including mergers, achievements, revenue offshoring, R&D, development plans, progression growth, and collaboration.

Global Breast Cancer Screening Market was valued at US$ 7,461.8 million in 2022 and is projected to surpass the market size of US$ 16,340.5 million by 2031 at a CAGR of 9.1% during the forecast period, 2023–2031.

Get Customized Reports with your Requirements :- https://www.astuteanalytica.com/request-sample/breast-cancer-screening-market

Report Scope

The report delves into the industry structure, sales, revenue, price, and gross margin of the global Breast Cancer Screening Market. It also presents information on major producers’ production locations, market shares, industry ranking, and profiles.

The research is based on primary and secondary statistics sources, including up-to-date government regulations, market information, and industry data. The data were collected from manufacturers, distributors, end users, industry associations, government-industry bureaus, industry publications, industry experts, third-party databases, and in-house databases.

Recent Market Trends

The global market report provides valuable insights into the major drivers and regional dynamics of the global keyword market, as well as current trends within the industry. The report also discusses the major players across each regional market and emphasizes the importance of technology and data for the industry’s future.

Competitive Landscape

The Global Breast Cancer Screening Market features a competitive landscape characterized by multinational corporations alongside regional players. The intense competition drives innovation and collaboration, with a focus on expanding product portfolios and meeting diverse consumer preferences for keywords.

Key Companies

· Siemens Healthcare

Hologic, Inc

Myriad Genetics

Metabolomic Technologies Inc

Biocrates Lifesciences AG

A&G Pharmaceuticals

Provista Diagnostics Inc

Roche Diagnostics

Lineage Cell Therapeutics, Inc. (Biotime Inc.)

General Electric Company

Quest Diagnostics

Agendia NV

Oncocyte Corporation

Allengers Medical Systems Ltd.

Other Prominent Players

𝐏𝐫𝐨𝐜𝐮𝐫𝐞 𝐂𝐨𝐦𝐩𝐥𝐞𝐭𝐞 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐑𝐞𝐩𝐨𝐫𝐭 𝐍𝐨𝐰 :- https://www.astuteanalytica.com/industry-report/breast-cancer-screening-market

Key Market Aspects

The report covers several key aspects of the global keyword market, including:

· Executive Summary: Summarizes vital studies, market trends, drivers, challenges, and macroscopic pointers.

· Study Analysis: Covers major companies, vital market segments, the scope of products offered, and the years measured.

· Company Profile: Screens each firm based on products, value, SWOT analysis, and other significant features.

· Manufacture by Region: Offers data on imports and exports, sales, production, and key companies in all studied regional markets.

Segmentation Outline

· By Test Type

Imaging Tests

Ultrasound

MRI

Mammogram

Film mammography

Digital mammography

Digital breast tomosynthesis (DBT)

Genetic Tests

Other screening Tests (Breast Exam, Thermography, Tissue sampling)

By End User

Research Labs

Cancer Institutes

Diagnostics Centers

Others

By Region

North America

The U.S.

Canada

Mexico

Europe

Western Europe

The UK

Germany

France

Italy

Spain

Rest of Western Europe

Eastern Europe

Poland

Russia

Rest of Eastern Europe

Asia Pacific

China

India

Japan

Australia & New Zealand

South Korea

ASEAN

Rest of Asia Pacific

Middle East & Africa (MEA)

Saudi Arabia

South Africa

UAE

Rest of MEA

South America

Argentina

Brazil

Rest of South America

𝐈𝐧𝐭𝐞𝐫𝐞𝐬𝐭𝐞𝐝 𝐭𝐨 𝐏𝐫𝐨𝐜𝐮𝐫𝐞 𝐭����𝐞 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐑𝐞𝐩𝐨𝐫𝐭? 𝐈𝐧𝐪𝐮𝐢𝐫𝐞 𝐁𝐞𝐟𝐨𝐫𝐞 𝐁𝐮𝐲𝐢𝐧𝐠 :- https://www.astuteanalytica.com/request-sample/breast-cancer-screening-market

About Astute Analytica:

Astute Analytica is a global analytics and advisory company that has built a solid reputation in a short period, thanks to the tangible outcomes we have delivered to our clients. We pride ourselves in generating unparalleled, in-depth, and uncannily accurate estimates and projections for our very demanding clients spread across different verticals. We have a long list of satisfied and repeat clients from a wide spectrum including technology, healthcare, chemicals, semiconductors, FMCG, and many more. These happy customers come to us from all across the globe.

They are able to make well-calibrated decisions and leverage highly lucrative opportunities while surmounting the fierce challenges all because we analyze for them the complex business environment, segment-wise existing and emerging possibilities, technology formations, growth estimates, and even the strategic choices available. In short, a complete package. All this is possible because we have a highly qualified, competent, and experienced team of professionals comprising business analysts, economists, consultants, and technology experts. In our list of priorities, you-our patron-come at the top. You can be sure of the best cost-effective, value-added package from us, should you decide to engage with us.

Get in touch with us

Phone number: +18884296757

Email: sales@astuteanalytica.com

Visit our website: https://www.astuteanalytica.com/

LinkedIn | Twitter | YouTube | Facebook | Pinterest

[apacnewsnetwork0]

Transforming Public Healthcare with Emerging Technologies: Insights from IAS Dr. Adapa Karthik, Sp. Secy, Health & Family Welfare, Punjab

New Delhi: In order to enhance healthcare services, there is a need to leverage cutting-edge technologies such as AI, ML, and innovative solutions to address public health challenges. By incorporating these emerging technologies, healthcare systems can become more efficient and improve overall public health outcomes.

IAS Dr. Adapa Karthik, Special Secretary, Department of Health & Family Welfare and Special Secretary cum Director, Department of Governance Reforms & Public Grievances, Government of Punjab, spoke at the APAC 6th National HealthTech Innovation Conclave. He spoke on the topic ‘Enabling Public Healthcare With Emerging Technologies’.

“In first world countries, AI and ML applications are now built on multi-modal data. Essentially, machines do well in terms of their intelligence when they have all forms of data, and that is where AI and ML are going to go,” Karthik said.

What is multi-modal data?

Multi-modal data refers to data collected from various sources or modalities, such as text, images, audio, video, or sensor data, which offer different perspectives on the same subject. This data is diverse, complementary, and often complex to handle, but it provides a rich and comprehensive understanding of the subject by incorporating information from multiple sources.

Applications of multi-modal data analysis can be found in fields like computer vision, natural language processing, and healthcare, where it enhances the performance of machine learning models and analytical tools by leveraging the synergies among different data sources.

Karthik then talks about the Bengaluru deep-tech startup company called NIRAMAI Health Analytix, that aims to counter critical healthcare issues through automated solutions.

A little about Niramai’s Breast Thermography

Known as Thermalytix, Niramai’s Breast Thermography is a healthcare technology for the early detection of breast cancer. It employs a non-invasive approach using thermal imaging to detect temperature variations in breast tissue.

By analysing these temperature patterns with artificial intelligence, Niramai’s system can assess the risk of breast cancer and provide early warnings, potentially improving the chances of successful treatment. It is a comfortable and radiation-free screening option, often used as a supplementary tool alongside mammography, especially for women with dense breast tissue or those who cannot undergo mammography for various reasons.

“The Government of Punjab has been able to screen about 20,000 women using the thermography equipment augmented by AI. This is the first ever example in the entire world where you have a large-scale AI-enabled screening tool to basically detect abnormalities in breasts,” he said.

Read more - https://apacnewsnetwork.com/2023/10/transforming-public-healthcare-with-emerging-technologies-insights-from-ias-dr-adapa-karthik-sp-secy-health-family-welfare-punjab/

[laurazukerman-blog]

Biopsies, Mammograms, Chemotherapy, Ultrasounds and Thermography

A Biopsy is a medical test where a small sample of tissue is taken from a part of the body to be examined under a microscope to detect any abnormalities in the cells and tissue. It is usually done to diagnose cancer or other diseases. Mammography is a type X-ray imaging that is used to screen and detect early signs of breast cancer. It is a non-invasive and painless procedure that uses low-dose…

[ameymeti2001]

Market for Breast Imaging to Reach $7.08 Billion by 2027

A research report titled "Breast Imaging Market by Technology [Ionizing (FFDM, Analog, 3D Mammogram, CT, CBCT), Non-Ionizing (Breast Ultrasound, Breast MRI, AWBU, Breast Thermography)], End User (Hospital, Diagnostic Imaging Center), and Geography - Forecast to 2027" was released by Meticulous Research®, a preeminent global market research company. This most recent article from Meticulous Research® claims that the breast imaging market is expected to grow at a CAGR of 9% from 2020 to 2027 to reach $7.08 billion by 2027. The growth in the breast imaging market is mainly attributed to the rising prevalence and incidence of breast cancer, growing awareness for early detection of breast diseases, technological innovations and launch of advanced breast imaging equipment & software, increasing investment and funding in R&D for breast cancer treatment, and rising women aging population. In addition, the extensive research in the development of hybrid imaging systems supports the growth of this market. However, the high cost of breast imaging equipment, errors associated with breast screening and diagnosis, and stringent regulatory approval procedure are the key factors expected to hinder the adoption of breast imaging.

The global breast imaging market study presents, historical market data in terms of value (2018 and 2019), estimated current data (2020), and forecasts for 2027 - by technology [ionizing (FFDM, analog, 3D mammogram, CT, CBCT), non-ionizing (breast ultrasound, breast MRI, AWBU, breast thermography)], end user (hospital, diagnostic imaging center), and geography. The study also evaluates industry competitors and analyzes their market share at the global and regional level.

Based on technology, the ionizing technology segment is estimated to account for the largest share of the overall breast imaging market in 2020. However, the non-ionizing technology segment is slated to grow with the fastest CAGR during the analysis period, due to their advantages over ionizing technologies such as high safety as no radiation exposure is required; accurate detection of breast tumor location; and higher sensitivity for smaller breast lesion.

Based on end user, the hospitals segment is estimated to account for the largest share of the overall breast imaging market in 2020. However, the ambulatory surgical centers segment is projected to register the fastest CAGR during the forecast period, mainly due to the factors such as rising preference for outpatient services and quick arrangement of diagnostic examinations for critical breast cancer patient by eliminating the waiting time at hospitals, less treatment cost, and new insurance plans for ASC treatment coverage.

Geographically, North America is estimated to command the largest share of the global breast imaging market in 2020, followed by Europe, Asia-Pacific, Latin America, and the Middle East & Africa. The major share of this region is mainly attributed to the factors such as high prevalence of breast cancer, greater adoption of advanced technologies, growing investments in cancer research activities, and presence of key players in the region. However, Asia-Pacific region is expected to be the fastest growing regional market during the forecast period. 

The key players operating in the global breast imaging market are Hologic, Inc. (U.S.), GE Healthcare (U.S.), Canon Inc. (Japan), Siemens AG (Germany), Koninklijke Philips N.V. (Netherlands), Carestream Health, Inc (U.S.), Planmed Oy (Finland), Hitachi, Ltd. (Japan),  Dilon Technologies Inc. (U.S.), CMR Naviscan Corporation (U.S.), FUJIFILM Holdings Corporation (Japan), Aurora Healthcare US Corp (U.S.), and SonoCine Inc. (U.S.) among others.

Scope of the Report:

Breast Imaging Market by Technology

Ionizing Technology

Full-Field Digital Mammography (FFDM)

3D Breast Tomosynthesis

Positron Emission Tomography/Computed Tomography (PET/CT)

Molecular Breast-Specific Gamma Imaging (MBI/BSGI)

Computed Tomography (CT)

Positron Emission Mammography (PEM)

Analog Mammography

Cone Beam Computed Tomography (CBCT)  

Non-Ionizing Technology

Breast Ultrasound

Breast MRI

Automated Whole-Breast Ultrasound

Breast Thermography

Optical Imaging

Breast Imaging Market by End User

Hospitals

Diagnostic Imaging Centers

Ambulatory Surgical Centers

Breast Imaging Market by Geography

North America

U.S.

Canada

Europe

Germany

U.K.

France

Italy

Spain

Rest of Europe (RoE)

Asia-Pacific (APAC)

Japan

China

India

Australia

Rest of APAC (RoAPAC)

Latin America

Middle East & Africa

𝑫𝒐𝒘𝒏𝒍𝒐𝒂𝒅 𝑺𝒂𝒎𝒑𝒍𝒆 𝑹𝒆𝒑𝒐𝒓𝒕 @https://www.meticulousresearch.com/download-sample-report/cp_id=4959?utm_source=product&utm_medium=Social&utm_campaign=Product&utm_content=20-02-2023

[flowwellblog-blog]

A thermography screening is the best solution in the cases of Breast cancer. With the help of it, she could have the opportunity to make healthy lifestyle decisions to take care of her cells.

[joseywritesng]

Breast Cancer Mammography vs Thermography

Breast Cancer Mammography vs Thermography

Women should continue to have regular mammograms to screen for breast cancer and not turn to thermography, the FDA and other breast cancer experts say, because thermography has not been shown to be effective in detecting breast cancer. Some spas, homeopathic clinics, and others have touted the use of thermography as an alternative to mammography. The FDA and cancer experts say there is no…

[btiscanint-blog]

Challenges with The Cold Stress Challenge for Breast Thermograpy

A. Piana, President of the Professional Academy of Clinical Thermology (PACT)Many if not most early thermologists utilized the Cold Stress Challenge to differentiate between insignificant thermal findings and the probability of breast cancer. There still are some today who use that system.The test is performed by taking a preliminary set of

thermal images

and comparing them to a subsequent set acquired after placing hand in cold water.  The change in thermal patterns are noted and an assessment is made.The Cold Stress Challenge is based up the function of the sympathetic nervous system. The sympathetic nervous system constricts normal capillaries during a stress response that slows down blood flow and cool the skin comparatively.  Normal tissue will physiologically respond to the challenge through vasoconstriction, while tumors lacking sympathetically controlled tissue will not. Stress responses may include loud noises, cold, or anything else that will create a fight or flight response.At face value this appears to be a viable method of differentiating between a cancer threat versus other causes of heat in the breast. There are however some complicating factors.

The breast itself is controlled by the nervous system originating from the spinal cord and emerging nerve roots that carry the sympathetic nerve fibers. It is common to see a cooling of the breast from a disc bulge or herniation that are compressing nerves and the spinal cord.  This cooling is a result of sympathetic vasoconstriction associated with the physical stress of the nerve compression in the spine.

Deeper lying tumors may be masked by sympathetic cooling on the surface of the breast on the cold challenge. Tumors at depth may conduct heat through the breast tissue and be identified at the surface. The cooling of the surface affects the ability to see tumors at depth.

As a tumor develops it becomes an acting part of the body. It develops blood flow through Angioneogenesis and it may develop capillaries controlled by the sympathetic nervous system.

Breast trauma and trauma to adjacent tissue may cause Complex Regional Pain Syndrome (CRPS) or Reflex Sympathetic Dystrophy (RSD) that cause the sympathetic nervous system to dysfunction.

There are more factors that can interfere with accurate testing with the cold stress challenge and may include brain pathology, breast surgery, spinal surgery, an any other condition that may alter the sympathetic nervous system.

The above listed conditions will affect the outcome and cause false negatives of the interpretation of

breast thermography

and should not be included in routine testing procedures.Most organizations have discontinued the use of the cold challenge in the 1990’s.  It is the stance of the Professional Academy of Clinical Thermology that the test should be reserved only for physician use on a case by case basis and discontinued as a routine screening.

https://btiscan.com/challenges-with-the-cold-stress-challenge-for-breast-thermograpy/

[perthmedicalimaging]

What Is The Difference Between Radiology And Perth Radiology Clinic

Diagnostic radiology refers to the techniques and processes used to create images of the human body for clinical purposes. Certain medical procedures are used to detect, diagnose, or examine the disease. Imaging of the organs and tissues can be performed as part of radiotherapy, in which images of the organs and tissues are generated to better detect the problem.

In general, physicians perform two types of radiographic images: projection radiography and fluoroscopy. In comparison to 3D tomography, these two-dimensional techniques are less expensive. Radiology, nuclear medicine, endoscopy, investigative radiological sciences, thermography, medical photography, and microscopy are all examples of biological imaging.

Get the best Radiology Centre in Perth

The Perth Radiology Centre provides you most convenient and affordable radiology services in Perth. The introduction of affordable and convenient radiology services, combined with government and charity-led initiatives to raise cancer awareness, has resulted in more people than ever having regular imaging tests performed.

Radiology equipment has become smaller, safer, and less expensive to operate in recent years, and images of excellent clarity can now be produced using a fraction of the doses of radiation previously possible. This enables patients to have regular mammograms with little risk to their health.

In the Perth Radiology clinic, modern scanners are cost-effective. They have established themselves with the best equipment, ensuring that a larger proportion of the population has access to the best radiology equipment. Screening becomes as quick and convenient as possible due to increased access to high-quality medical facilities.

While the services are provided, the message about the importance of regular screenings and how early detection of cancer can greatly improve survival rates from this devastating disease must be spread. Cancer becomes more difficult to treat as it progresses. 

Detecting illness in its early stages is therefore critical to increase the likelihood of treatment success and a patient's full recovery. Medical experts universally agree that men and women must prioritize their health, not only daily by eating healthier and exercising regularly, but also by getting regular cancer screenings.

Regular medical imaging tests and examinations can help to ensure that, if cancer strikes, the appropriate treatment is administered as soon as possible while it is most effective. Annual mammograms or ultrasound imaging tests can significantly improve breast cancer survival rates.

About the company

Perth Medical Imaging radiology clinic is now offering bulk-billed radiology services to pay for diagnostic screening tests like ultrasound imaging and mammograms. Patients' out-of-pocket expenses are reduced when radiology services are bulk billed.

[thelatestnews1]

Breast Cancer Mammography vs. Thermography

Breast Cancer Mammography vs. Thermography

Women should continue to get regular mammograms to screen for breast cancer and not turn to thermography, the FDA and other breast cancer experts say, because thermography hasn’t been shown to be effective at detecting breast cancer. Some health spas, homeopathic clinics, and others have touted the use of thermography as an alternative to mammography. The FDA and cancer experts say there is no…

[health28]

Breast Cancer Mammography vs. Thermography

Breast Cancer Mammography vs. Thermography

Women should continue to get regular mammograms to screen for breast cancer and not turn to thermography, the FDA and other breast cancer experts say, because thermography hasn’t been shown to be effective at detecting breast cancer. Some health spas, homeopathic clinics, and others have touted the use of thermography as an alternative to mammography. The FDA and cancer experts say there is no…

[lorphic-news]

50% of Women Had a False-Positive Mammogram After 10 Years

STORY AT-A-GLANCE - Data once again show mammograms don't deliver on the promise of effective breast cancer screening as more than half of women in one study had a false positive after 10 years of testing - In addition to the added risk from radiation in mammograms that triggers fatal cancer in up to 25 of 100,000 women, the screening does not efficiently identify all cancers, especially in women with dense breasts - Women have choices for screening that do not involve radiation, including thermography, ultrasound and clinical breast examination - They can also practice healthy lifestyle choices to reduce risk and maintain optimal levels of omega-3 fatty acid and vitamin D By Dr. Joseph Mercola (Mercola) The effectiveness of consistent early screening mammograms has been studied for many years with mixed results. Current research published by the University of California in March 2022, showed half of all women who got annual mammograms will experience at least one false-positive test after 10 years.1 False-positive testing from mammography as a screening tool can lead to overdiagnosis and overtreatment, including unnecessary biopsies.2 A past study3 from the John Wayne Cancer Institute revealed needle biopsy can increase the spread of cancer compared to patients who received excisional biopsy, also known as lumpectomies. After a false-positive mammography, needle biopsies are widely used to diagnose breast cancer. But this can accidentally cause malignant cells to spread from the tumor site and encourage metastasis to form in other areas of your body. The researchers from John Wayne Cancer Institute concluded:4 "Manipulation of an intact tumor by FNA or large-gauge needle core biopsy is associated with an increase in the incidence of SN metastases, perhaps due in part to the mechanical disruption of the tumor by the needle." There's also a significant financial cost to annual mammogram screenings. According to the American Cancer Society,5 73% of women over 45 had a screening mammogram within the past 2 years. In the U.S., these percentages add up to an overwhelming number of women. As of July 1, 2020, there were 62.03 million women from 40 to 70 years in the U.S.6 Assuming the average out-of-pocket cost for a mammogram in the U.S. is roughly $100,7 the total revenue generated is in the billions of dollars. But the financial cost is not the only downside to annual mammogram testing, and women do have other choices for effective screening. False-Positive Mammograms Are Not Uncommon The featured study8 was published in JAMA Oncology in March 2022. The researchers asked the question if there was a difference between screening for breast cancer using traditional digital mammography or 3D mammography, also called digital breast tomosynthesis. Data were collected between January 1, 2005, and December 31, 2018, at 126 facilities. It included 903,495 women aged 40 to 79 years. The results showed there were 2,969,055 nonbaseline screening mammograms interpreted by 699 radiologists; 58% of those mammograms were performed in women younger than 60 years. Importantly, it was also noted that 46% of these mammograms were on women who had dense breast tissue. Michael Bissell, epidemiologist in the UC Davis Department of Public Health Sciences and researcher in the study, said in a press release:9 "The screening technology did not have the largest impact on reducing false positives. Findings from our study highlight the importance of patient-provider discussions around personalized health. It is important to consider a patient's preferences and risk factors when deciding on screening interval and modality." After data collection, the researchers analyzed the type of mammography used, screening interval, age of the woman and breast density. From this data, they estimated that a woman would have a cumulative risk of at least one false positive after receiving mammograms each year or every other year for 10 years.10 The analysis also showed a false positive resulted in repeated imaging within six months or a biopsy recommendation. The scientists then separated the data for 2D and 3D digital mammography, theorizing that 3D may have a lower risk of a false positive test. While the theory was proved by the data, the reduction in risk was minimal. They estimated that over 10 years of 3D screening, 50% of women had at least one false-positive test while 56% of those receiving traditional digital mammography had at least one false positive. The comparison between those who had short interval follow-up recommendations and biopsy recommendations differed by only 1%. Mammograms May Not Work for Women With Dense Breasts The researchers also found that regardless of whether women had 2D or 3D mammography, the false-positive results were higher in women who had extremely dense breasts.11 The difference between false positives in women who had entirely fatty breasts and those with dense breasts was significant. Using 3D mammography, women with entirely fatty breasts had a 31% probability of a false positive test, while those with dense breasts had a 67.3% probability of a false positive test.12 The researchers also found that, in general, between both types of mammography, women who had almost entirely fatty breasts had a lower probability of a false positive test as compared to women with extremely dense breasts. Additionally, women with dense breasts did not benefit from cancer detection with tomosynthesis. In addition to the problem with overdiagnosis is the reality that mammograms do not detect all breast cancer. The documentary, “Boobs: The War on Women’s Breasts” available on DVD or Vimeo digital,13 tells the story of Nancy Cappello. Capello was diagnosed with breast cancer after receiving two normal mammograms. Capello's cancer was missed because she had dense breast tissue. It was only found when her doctor felt the ridge in her breast and prescribed an ultrasound in addition to a mammogram. Capello became a pioneer in the movement to teach women about dense breast tissue and how using a mammogram is "like finding a polar bear in a snowstorm." She said:14 "So I went on a quest — for research — and I discovered for nearly a decade BEFORE my diagnosis, six major studies with over 42,000 women concluded that by supplementing a mammogram with an ultrasound increases detection from 48% to 97% for women with dense tissue. I also learned that women with extremely dense tissue are 5x more likely to have breast cancer when compared with women with fatty breasts and that research on dense breast tissue as an independent risk factor for breast cancer has been studied since the mid 70s. … I endured a mastectomy, reconstruction, 8 chemotherapy treatments and 24 radiation treatments. The pathology report confirmed — stage 3c cancer because the cancer had traveled outside of the breast to my lymph nodes. Eighteen lymph nodes were removed and thirteen contained cancer — AND REMEMBER — a "normal" mammogram just weeks before. Is that early detection?" Cappello succumbed to her breast cancer in 2018 and died after a 15-year fight to beat her cancer,15 but as a result of her efforts, 38 states have passed mandatory breast density reporting laws. The film states that up to 90% of women may have some degree of dense breast tissue that may affect a mammogram's outcome and could benefit from whole breast ultrasound — a procedure that's generally used as an adjunct to a mammogram, rather than a primary test.16 Mammography Radiation Is Not Without Risk There's also the issue that mammograms use ionizing radiation in a relatively high dose. This, in and of itself, can contribute to the development of breast cancer. A 2016 study concluded:17 "… ionizing radiation as used in low-dose X-ray mammography may be associated with a risk of radiation-induced carcinogenesis." The researchers pointed out that women who carry a genetic variation or have an inherited disposition of breast cancer should avoid radiation as much as possible. Unfortunately, conventional medicine often recommends routine or even extra mammography for those who have an inherited disposition for breast cancer18 or a genetic mutation.19 The next generation of mammography, 3D tomosynthesis, is basically a CT scan for the breast. Radiation exposure from this is even greater than standard mammograms by a significant margin. According to one study,20 annual screening using digital or film mammography on women aged 40 to 80 years is associated with an induced cancer incidence and fatal breast cancer rate of 20 to 25 cases per 100,000 mammograms. This means an annual mammogram could cause 20 to 25 cases of fatal cancer for every 100,000 women who got the test. A 3D mammography requires multiple views to get the three-dimensionality. It stands to reason your total radiation exposure is considerably higher than from a standard 2D mammogram. Additionally, data do not support screening asymptomatic women as it is not saving extra lives. A response published in The BMJ21 to research published in The Lancet22 was written by Hazel Thornton, an honorary visiting fellow in the department of health sciences at the University of Leicester. She included reports on her testimony before the House of Commons Health Committee on breast cancer services. She was asked why she thought the NHS Breast Screening Programme was “a costly trawl of an asymptomatic public group … creating huge costly psychological and physical morbidity,” to which part of her answer was that it:23 “… focuses on the women who benefit, in other words, the one life that is saved, and it overlooks the hundreds of women that go through the process and in some cases suffer psychological harm for that one. It is unbalanced and disproportionate and should be reviewed, in my opinion, at the moment.” In a Cochrane review of the literature24 they discovered — as Thornton testified — for every 2,000 women screened over 10 years, one avoids dying of breast cancer, and 10 will be treated unnecessarily. Additionally, over 200 women will undergo psychological distress and uncertainty for years after receiving false-positive findings. One cohort study25 engaged participants in Denmark from 1980 to 2010. They also found screening did not lower the incidence of advanced tumors and concluded “that 1 in every 3 invasive tumors and cases of DCIS diagnosed in women offered screening represent overdiagnosis (incidence increase of 48.3%).”26 You Have Choices Although mammography is the most frequently recommended breast cancer screening tool, you have choices for diagnostic testing that do not involve radiation. Women should be provided enough information to make an informed decision and allowed to use their choice. When you know the options, you can ask to have the test that best suits your situation. Other potentially safer options for breast examination include clinical breast exams, thermography and ultrasound. Thermography and ultrasound don't use radiation and can detect abnormalities that mammograms can miss, especially in women with dense breasts. While it’s also claimed that mammography can catch cancers that an ultrasound misses; according to the National Institutes of Health, “… researchers do not know with full certainty whether 3D mammography is better or worse than standard mammography at avoiding false-positive results and identifying early cancers in all types of patients.”27 Not only that, the U.S. Preventive Services Task Force (USPSTF) on breast cancer screening admits that “… the current evidence is insufficient to assess the benefits and harms of digital breast tomosynthesis (DBT) as a primary screening method for breast cancer.”28 Although they are effective, alternative tests can be difficult to access in the U.S. due to federal guidelines and the influence of the billion-dollar mammography industry. To deny women the use of these screening programs, the USPSTF claims: “… current evidence is insufficient to assess the balance of benefits and harms of adjunctive screening for breast cancer using breast ultrasonography, magnetic resonance imaging, DBT, or other methods in women identified to have dense breasts on an otherwise negative screening mammogram.” It's also important to recognize that screening does not prevent breast cancer. Instead, prevention requires healthy lifestyle choices, paying attention to nutritional factors and avoiding toxins. For example, vitamin D is of vital nutritional factor that can reduce your risk of all cancer,29 including breast cancer.30 Animal and human studies have also demonstrated that omega-3 fatty acids can help prevent breast cancer and have a positive effect during breast cancer treatment.31 To understand your potential risk, it's crucial that you know your vitamin D level and omega-3 index. Conventional medicine has led many women to believe that simply getting an annual test will protect them from breast cancer. Leading a healthy lifestyle and being informed of your screening options can help you avoid this potentially deadly pitfall. - 1 JAMA Network, 2022; 5(3) - 2 Current Oncology, 2015;22(5) - 3, 4 JAMA Surgery, 2004;139(6) - 5 American Cancer Society, Breast Cancer Facts and Figures 2019-2020 Table 5 - 6 Statistica, Resident Population of the United States by Sex and Age, July 1, 2020 - 7 Cost Helper Health, How Much Does a Mammogram Cost? - 8 JAMA Oncology, 2022;5(3) Question and Findings - 9, 11 Science Daily, March 25, 2022 - 10 Science Daily, March 25, 2022 subhead 2 para 2 and all subhead 3 - 12 JAMA Oncology, 2022;5(3) Results, False positive recall - 13 Vimeo, August 29, 2020 - 14 AreYouDense.org, Nancy’s Story - 15 New York Times November 28, 2018 - 16 Johns Hopkins Medicine - 17 Medical Principles and Practice 2016;25(2) - 18 Journal of the American College of Radiation, 2018; 15(supp 3) - 19 BreastCancer.org, April 15, 2020, Guideline Recommendations - 20 Radiology, 2010; doi.org/10.1148/radiol.10100570 - 21, 23 The BMJ, 2020;370:m3191 - 22 The Lancet Oncology, 2020; doi.org/10.1016/S1470-20245(20)30398-3 - 24 Cochrane Library, 2013; doi.org/10.1002/14651858.CD001877.pub5 - 25, 26 Annals of Internal Medicine, 2017; doi.org/10.7326/M16-0270 - 27 NIH. Mammography - 28 U.S. Preventive Services Task Force. Breast Cancer: Screeening. January 11, 2016 - 29 National Cancer Institute, Vitamin D and Cancer Prevention - 30 The Oncologist, 2012;17(1) - 31 Breast Cancer Research, 2015;17(1) starting 40% down the page with subhead How might EPA and DHA act to prevent breast cancer? Read the full article

[mammographysystems102]

Testing For Breast Cancer With No Compression And No Radiation

Who would have believed that a modern technology for identifying breast cancer cells utilized today actually had its' roots going back to 480 B.C.? Digital Infrared Thermal Imaging (DITI) is a fairly brand-new technology that represents a technique that was when utilized by Hippocrates. This innovation is based on a method that Hippocrates would make use of as he spread out mud over his people as well as after that saw to see which areas dried. It remained in those position on the body that might show a condition.

It had not been until 1957 that the first modern-day application of thermography came into existence when a Canadian medical professional discovered that the skin temperature over a bust tumor was more than that of healthy and balanced cells. By 1982, the Food and Drug Administration accepted thermography and categorized it as an extra analysis device for the discovery of bust cancer cells. DITI was introduced as an analysis tool before strict procedures were established for both the service technicians who carried out the scans and the medical professionals who translated the scans. Shortly after its initial beginnings, DITI fell out of support as a diagnostic tool in the clinical neighborhood.

There are now rigid procedures both for testing as well as translating. Maybe as a result of these guidelines, thermography (similar to all digital innovation) has actually blown up in its method and also capabilities. Thermal cameras identify warmth given off by the body as well as show it as an image on a computer system screen. These pictures are distinct to the individual and also they continue to be stable gradually. It is because of these characteristics that thermal imaging is an important and also reliable testing device to figure out adjustments that might point to difficulty down the road. As we all understand, early cancer detection is essential to survival. Click over here https://umacglobal.com/products/mammography/hologic-dimensions-3d-mammography/

One more advantage is that, unlike mammography, there is no radiation as well as no compression of the breast; 2 substantial reasons some females decline mammography. Thermography gauges temperature adjustments in the body. Lumps develop their very own blood vessels. Where there are much more capillary, there is more warmth. It is in these areas on the body that the camera spots adjustments in warm or temperature.

Clinical doctors who interpret the bust scans are board licensed thermologists.

Thermography can be made use of by females of any ages. It is not limited by breast density and is suitable for women that have actually had aesthetic or reconstructive surgery. Cancer commonly has a 15 year lifetime from beginning to fatality. Ideally, ladies need to start thermographic testings by age 25. A woman identified with breast cancer cells at age 40 perhaps had the cancer as early as age 30. Considering that the majority of women do not have a mammogram until age 40, there is a critical amount of time from age 25 to 39 that thermography could be incredibly advantageous.

Thermography does not replace mammography. Nevertheless, it is an extra tool that is offered to ladies. By combining both innovations, the discovery price increases to 95-98%, exceeding either modern technology as a stand-alone treatment.

[rahulg1122]

Breast Imaging Market Worth $5.4 Billion by 2025

According to the new market research report "Breast Imaging Market by Technology [Mammography (FFDM, Digital & 3D Mammography), Breast Ultrasound, MRI, CBCT, MBI, PET-CT, ABUS, Optical Imaging], End user (Hospitals & Clinics, Breast Care Centers, Diagnostic Imaging Centers) – Global Forecasts to 2025", published by MarketsandMarkets™, the Breast Imaging Market is projected to reach USD 5.4 billion by 2025 from USD 3.6 billion in 2020, at a CAGR of 8.1% during the forecast period. 

Technological advancements in the field of breast imaging and the rising incidence of breast cancer are the major factors driving the growth of this market. Additionally, the growing adoption of advanced techniques for breast cancer screening and rising government and private investments for improving breast cancer care are some of the other major factors driving the growth of this market. 

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=897 

The ionizing breast imaging segment accounted for the largest share of the breast imaging market, by technology, in 2019

Based on technology, the market is segmented into ionizing imaging technologies and non-ionizing imaging technologies. The ionizing breast imaging technology segment accounted for the largest share of the breast imaging market during the forecast period. The large share of this market segment is primarily due to the technological advancements in ionizing breast imaging technologies and rising awareness about the early screening and diagnosis of breast cancer.

Mammography to dominate the ionizing imaging technologies market during the forecast period

Ionizing imaging technologies segment is categorized into five subsegments, namely, mammography (analog mammography, full-field digital mammography (FFDM), 3D breast tomosynthesis), positron emission tomography-computed tomography (PET-CT), molecular breast imaging/breast-specific gamma imaging (MBI/BSGI), positron emission mammography (PEM), and cone-beam computed tomography (CBCT). Mammography is expected to account for the largest share of the ionizing breast imaging technologies segment during the forecast period. The major share of the segment is attributed to technological advancements and favorable reimbursement scenario in most of developed countries.

AWBU to register highest growth over the forecast period among non- ionizing imaging technologies

The non-ionizing breast imaging technologies market is further sub-segmented into breast MRI, breast ultrasound, automated whole-breast ultrasound (AWBU), breast thermography, electric impedance tomography, and optical imaging. The AWBU segment is expected to register highest growth over the forecast among the non-ionizing breast imaging technologies market over the forecast period. The significant growth of this segment is attributed to the advantages offered by the systems, technological advancements, and rising awareness about early cancer detection.

Get a Sample Report: https://www.marketsandmarkets.com/requestsampleNew.asp?id=897

North America to dominate the breast imaging market during the forecast period

The breast imaging market is segmented into five regional segments, namely, North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The North American region accounted for the largest share of the breast imaging market in 2019. The rising incidence of breast cancer, easy accessibility and high adoption of advanced diagnostic technologies (owing to the significant per capita annual healthcare expenditure in the US and Canada), presence of a favorable reimbursement scenario, and the rapidly increasing geriatric population in the region are some of the major factors driving the growth of the breast imaging market in North America.

The major players operating in the breast imaging market are Hologic, Inc. (US), GE Healthcare (US), Siemens Healthineers (Germany), Koninklijke Philips N.V. (Netherlands), Fujifilm Holdings Corporation (Japan), Canon Inc. (Japan), Aurora Healthcare US Corp. (US), Allengers (India), Dilon Technologies, Inc. (US), Planmed Oy (Finland), Delphinus Medical Technologies, Inc. (US), Micrima Limited (UK), CMR Naviscan Corporation (US), SuperSonic Imagine (France), and Carestream Health (US).